Pacira’s Q2 EXPAREL® sales figure has triggered an $8m sales milestone to Vectura for annual net sales to 30 June 2016 exceeding $250m, in line with our expectations. The Q2 sales figure of $65.8m showed 3% growth on Q1 and a twelve month sales figure of $256.5m. Pacira reinstated financial guidance yesterday and is guiding to EXPAREL® net sales of $270m to $280m in 2016. Pacira is positive on the prospects for EXPAREL® and is on track to launch the product in oral surgery in September 2016. We ....
